A method of treating hemodynamic disfunction by simultaneously pacing both ventricles of a heart. At least one ECG amplifier is arranged to separately detect contraction of each ventricle and a stimulator is then activated for issuing stimulating pulses to both ventricles in a manner to assure simultaneous contraction of both ventricles, thereby to assure hemodynamic efficiency. A first ventricle is stimulated simultaneously with contraction of a second ventricle when the first fails to properly contract. Further, both ventricles are stimulated after lapse of a predetermined A-V escape interval. One of a pair of electrodes, connected in series, is placed through the superior vena cava into the right ventricle and a second is placed in the coronary sinus about the left ventricle. Each electrode performs both pacing and sensing functions. The pacer is particularly suitable for treating bundle branch blocks or slow conduction in a portion of the ventricles.

Patent
   RE38119
Priority
Jan 23 1989
Filed
Oct 19 1995
Issued
May 20 2003
Expiry
Jan 23 2009
Assg.orig
Entity
unknown
148
8
EXPIRED
0. 19. A method for improving the hemodynamic efficiency of a heart comprising the steps of:
sensing a contraction of the atria; and
stimulating both ventricles for effecting a coordinated contraction of both ventricles when a contraction of the atria is sensed and following a predetermined A-V delay period.
0. 25. A bi-ventricular pacemaker comprising:
detecting means for detecting a cardiac signal resulting from a contraction of a first ventricle;
stimulating means for effecting immediate and unconditional contraction of a second ventricle in response to the detected cardiac signal, thereby effecting simultaneous contraction of both ventricles.
0. 15. A method for improving the hemodynamic efficiency of a heart comprising the steps of:
detecting a cardiac depolarization signal originating from a first ventricle;
immediately and unconditionally stimulating both ventricles for effecting a coordinated contraction of both ventricles when a cardiac depolarization signal originating from the first ventricle is detected.
0. 22. A bi-ventricular pacemaker, comprising:
sense means for sensing ventricular depolarization signals originating from one of left and right ventricles; and
pulse generator means operative upon sensing a depolarization signal from the one of the ventricles for producing a stimulating pulse and immediately and unconditionally applying the stimulating pulse to both ventricles.
5. A method for effecting simultaneous contraction of both left and right ventricles of a heart for improving hemodynamic efficiency comprising the steps of:
separately sensing for the presence of cardiac depolarization signals from both left and right ventricles;
determining whether said cardiac depolarization signals are simultaneously present in both the left and right ventricles; and
stimulating at least one ventricle substantially simultaneously with the contraction of a least one other ventricle in the event that said cardiac depolarization signals are determined not to be simultaneously present in both ventricles.
6. A method of effecting simultaneous contraction of both left and right ventricles of a heart for improving hemodynamic efficiency comprising the steps of:
sensing the cardiac signals of the atria and separately sensing the cardiac depolarization signals of both the left and right ventricles;
determining whether said cardiac depolarization signals are simultaneously present in both the left and right ventricles;
stimulating at least one ventricle simultaneously with the contraction of at least one other ventricle after a predetermined A-V period in the event that said cardiac depolarization signals are determined not to be simultaneously present in both ventricles.
9. A bi-ventricular pacemaker, comprising:
(a) sense means for sensing ventricular depolarization signals originating in or on the right and left ventricles;
(b) means coupled to said sense means for initiating a time delay of a predetermined length which is short compared to the period of a qrs complex upon detection of a ventricular depolarization signal in one of said right or left ventricles; and
(c) pulse generator means operative upon the termination of said time delay for producing a ventricular simulating pulse and applying same to the other of said right or left ventricles unless a ventricular depolarization signal occurs in said other of said right or left ventricle prior to the expiration of said time delay.
7. A method of increasing the cardiac output of a sick heart comprising the steps of:
(a) implanting a pacing lead having at least two sensing/pacing electrodes in the body such that one of said sensing/pacing electrodes is in or on the right ventricle and the other of said sensing/pacing electrodes is in or on the left ventricle;
(b) sensing depolarization signals picked up by said sensing/pacing electrodes upon their occurrence;
(c) determining whether the depolarization signals sensed in step (b) fail to occur within a predetermined time interval of one another and, if so;
(d) applying an electrical stimulating pulse to the sensing/pacing electrode associated with the ventricle not producing a depolarization signal within said time interval at the conclusion of said time interval.
1. A method for improving the hemodynamic efficiency of a sick heart comprising the steps of:
(a) detecting respective cardiac signals originating in the left and right ventricles of the heart;
(b) analyzing said cardiac signals and the absence thereof in an electronic control circuit; and
(c) providing electrical pulses from a stimulating circuit controlled by said control circuit to one, the other or both ventricles as required for effecting substantially simultaneous contraction of both ventricles, said step of analyzing including providing a control signal from said control circuit to said stimulating circuit for producing an electrical stimulating pulse to one or both ventricles in response to the absence of a detected cardiac signal from one or both ventricles within a time interval which is a small fraction of the pulse width of a detected cardiac signal.
13. An atrial-coupled, bi-ventricular pacemaker for implantation or external use comprising atrial and ventricular sensing means for detecting cardiac signals, said sensing means including first and second ventricular electrodes connected in series for sensing and stimulating the right and left ventricles, respectively, and an atrial electrode adapted to be disposed in an atrial chamber for detecting cardiac signals of the atria, all of said electrodes being connected to separate ECG amplifier means for amplifying the sensed signals; a control circuit coupled to said ECG amplifier means for analyzing the cardiac signals picked up by said sensing means and providing a control signal; and a stimulating circuit means for producing an electrical stimulating pulse to the left ventricle in the absence of a detected cardiac signal from the left ventricle, and to the right ventricle in the absence of a detected cardiac signal from the right ventricle, and to both ventricles in the absence of detected cardiac signals from both ventricles to effect substantially simultaneous contraction of both ventricles after a predetermined A-V delay period.
2. The method of claim 1 wherein said step of detecting respective cardiac signals comprises deposing electrodes in or on the left and right ventricles for separately detecting the respective cardiac signals of the left and right ventricles, and applying said cardiac signals to separate ECG amplifier means connected to each of said electrodes to amplify the cardiac signal for analysis.
3. The method of claim 2 wherein said step of providing electrical pulses includes delivering an electrical pulse from said stimulating circuit to said electrodes in or on both the left and right ventricles.
4. The method of claim 1 wherein said step of analyzing further includes providing a control signal from said control circuit to the stimulating circuit to produce an electrical stimulating pulse to the left ventricle in the absence of a detected cardiac signal from the left ventricle, or to the right ventricle in the absence of a detected cardiac signal from the right ventricle, or to both ventricles in the absence of detected cardiac signals from both ventricles.
8. The method as in claim 7 wherein said predetermined time interval is in the range of from about 5 ms. to 10 ms.
10. The bi-ventricular pacemaker as in claim 9 wherein said sense means comprises a bi-ventricular lead having a first electrode for contacting the left ventricle and sense amplifier means electrically coupled to said first and second electrodes.
11. The bi-ventricular pacemaker as in claim 10 wherein said means coupled to said sense means includes:
(a) first and second set-reset flip-flop connected to be set by an output from said sense amplifier means;
(b) presetable counter means for initially containing a digital value representative of said time delay;
(c) means for incrementing or decrementing said digital value in said presettable couter means at regular intervals until a predetermined count is reached;
(d) means responsive to the value in said counter means reaching said predetermined count for producing a control signal;
(e) logic means coupled to said first and second flip-flops and to said presettable counter means for receiving said control signals; and wherein
(f) said pulse generator means is enabled by said logic means.
12. The bi-ventricular pacemaker as in claim 11 wherein said pulse generator means is coupled to said first and second electrodes.
14. The pacemaker of claim 13 wherein said first electrode is adapted to be placed in the right ventricle and the second electrode is adapted to be placed in the coronary sinus extending about the left ventricle.
0. 16. The method of claim 15 wherein the step of immediately and unconditionally stimulating both ventricles further comprises providing electrical pulses from a stimulating circuit to both ventricles.
0. 17. The method of claim 16 wherein said step of detecting a cardiac depolarization signal further comprises positioning electrodes in or about both ventricles for detecting cardiac depolarization signals and for conducting a signal to an electronic control circuit for controlling the stimulating circuit.
0. 18. The method of claim 17 wherein said step of detecting a cardiac depolarization signal further comprises conducting the signal to an amplifier means to amplify the detected signal, and applying the amplified signal to the control circuit.
0. 20. The method according to claim 19, further comprising, before said sensing step:
placing a first electrode into the right ventricle through the superior vena cava and placing a second electrode into the left ventricle through the coronary sinus;
wherein said stimulation of both ventricles is an electrical discharge through said first and second electrode.
0. 21. The method according to claim 19, further comprising, before said sensing step:
placing a pair of sensing and pacing tip electrodes into each of the right and left ventricles;
wherein said sensing is detected through said pair of sensing tip electrodes.
0. 23. A bi-ventricular pacemaker according to claim 22, wherein the sense means includes a lead having a first electrode for placement in or about the left ventricle and a second electrode for placement in or about the right ventricle.
0. 24. A bi-ventricular pacemaker according to claim 22, wherein the pulse generator means includes a sense amplifier means electrically coupled to the first and second electrodes for amplifying a sensed depolarization signal, a stimulating circuit for producing the stimulating pulse, and a control circuit operative to control the stimulating circuit in response to the amplified sensed depolarization signal.
0. 26. A bi-ventricular pacemaker according to claim 25 further comprising stimulating means for providing a stimulating pulse to the first ventricle simultaneous with the effecting of the immediate and unconditional contraction of the second ventricle.

FIG. 1 illustrates the overall pacing system which may be employed for carrying out the teachings of the invention. A pair of leads 12 and 14 with corresponding sensing/stimulating tip electrodes 13 and 15 are electrically connected, via conductors 18 and 21, to separate ECG sense amplifiers 16 and 17 (or to a single multiplexed amplifier). The amplifiers 16 and 17 are both connected to a control circuit unit 20. A stimulator circuit 22 is connected to the control unit 20 and has two output conductor lines 24 and 26 which are electrically connected to the conductors 18 and 21, respectively. From this structure, signals my be separately sensed by the electrodes 13 and 15 and stimulating pacing signals may be separately delivered to the electrodes 13 and 15, via lead branches 12 and 14.

In operation, the electrodes 13 and 15 are disposed in or about the right and left ventricles, respectively. A preferred surgical procedure for implanting the lead 12 is to extend it through the superior vena cava 28 so that the sensing stimulating tip 13 thereof lodges in the internal chamber of the right ventricle of the heart 10. A preferred surgical procedure for implanting lead branch 14 is to extend it through the coronary sinus (not shown) of the heart 10 so that the sensing/stimulating tip 15 thereof lodges directly in or about the coronary simus and left ventricle. Although it is described that electrodes 13 and 15 perform both sensing and pacing, it is possible for testing and examination, that separate unipolar or bipolar sensing and stimulating electrodes may be used.

When attached to the heart, the electrodes 13 and 15 sense cardiac signals in the form of well-known Q-R-S complex at separate sites with the left and right ventricles. The ECG amplifiers 16 and 17 feed the amplified versions of these signals to the control circuit 20.

The control circuit 20 analyzes the cardiac signals to determine whether an abnormal conduction exists. Specifically, if a cardiac signal is received from the left ventricle but not from the right ventricle, the control circuit 20 provides a control signal to the stimulator 22 to issue a stimulating pacing pulse over conductors 24 and 18 and lead branch 12 to the right ventricle, via the sensing/stimulating tip electrodes 13. Similarly, the control circuit 20 provides a control signal to the stimulator 22 to issue a stimulating pacing pulse over lead branch 14 to the left ventricle, via sensing/stimulating tip electrode 15, if a cardiac depolarization signal is received from the right ventricle, but not from the left ventricle. It is also possible to sense a depolarization signal from only one ventricular chamber and then unconditionally stimulate both ventricular chambers. This is wasteful of powe which is a concern only if the stimulator is totally implanted and must rely on an implanted battery power source.

The timing of the stimulating pacing pulse from the stimulator 22 is such that both ventricles will contract substantially simultaneously. Where both ventricles are unconditionally stimulated upon the occurrence of a QRS complex on only one side, the fact that ventricular site which had produced a Q-R-S complex is immediately stimulated along with the other ventricle does not cause a problem since the site producing that complex is still refractory at the time it is stimulated.

It is also possible that no cardiac signals are sensed from either ventricle, possibly resulting from complete conduction failure between the sinoatrial node and the atrialventricular node. In this case, the control circuit 20 will again activate the stimulator 22 to provide stimulating signals to both ventricles simultaneously.

In an alternative embodiment of this invention, the issuance of pacing pulses to the ventricles is time-coupled to the rhythmic cycle of the atrial beat of the heart to preserve a preset atrial-ventricular delay period of about 120 to 200 milliseconds. Additional atrial sensing is accomplished, via lead 23 and a sense electrode 25 similar to the ventricular leads 12 and 14, but disposed in or about the right atrial chamber and connected to the control circuit 20, via atrial sense amplifier 27. The control circuit 20 may be configured to respond to the sensed atrial and ventricular signals to activate the stimulator for providing appropriate simultaneous stimulating signals to the ventricles as described above in accordance with the predetermined A-V delay period.

In the case where the conduction of the natural stimulating signal originating at the sinoatrial node of the heart 10 is only partially blocked or slowed, the ventricles may partially or incompletely contract, in which case hemodynanmic efficiency is reduced. Under these circumstances, provision is made in the control circuit 20 for determining whether a Q-R-S cardiac signal, although present, is weak or slow, and if so, to activate the stimulator 22 to stimulate the ventricles of the heart by passing pacing pulses simultaneously thereto.

FIG. 2 shows one embodiment of the control circuitry 20 of FIG. 1 required to perform bi-ventricular pacing. Also shown in the circuit of FIG. 2 are means for interconnecting the bi-ventricular control circuitry with conventional demand pacing circuitry to implement various additional pacing modes. It is understood that in the preferred embodiment, the circuitry shown in FIG. 1 would be preferably incorporated directly into the design of a pacer rather than its adjunctive form shown here for purposes of illustration.

To accomplish bi-ventricular pacing, activity is sensed in both the left and the right ventricle. When a ventricular contraction is sensed in either ventricle, a timer is initiated. If within a time window established by said timer, the contraction is sensed in the other ventricle, all pacing is inhibited because the natural contractions are deemed to be simultaneous. On the other hand, if ventricular contractions are not sensed in both ventricles within a period of coincidence defined by the time delay, at the end of this delay, the pacing pulse will be emitted, but only to the ventricle for which a QRS complex has not been sensed. Generally, ventricular contractions which occur with 5-10 milliseconds of each other result in sufficient hemodynamic efficiency so as to not require treatment. Hence, the delay window may be of this order of magnitude. As used herein, the term "substantially simultaneous contraction" includes the occurence of natural contractions of both ventricles with the window period or an evoked contraction of one or both ventricles immediately following the expiration of the window period.

Operation of the circuit of FIG. 2 will now be described. Electrical activity originating in the left ventricle is sensed by electrode 15 on lead 14 coupled to amplifier 16. It is assumed that amplifier 16 contains all of the thresholding and inhibiting provisions commonly utilized in existing pacing systems to inhibit all electrical activity, save valid ventricular contractions. Similarly, electrical activity in the right ventricle is sensed by electrode 13 on lead 12 and processed by ECG amplifier 17.

Let if first be assumed that a left ventricle contraction procedes that of the right. In this case, an R-wave signal propagates through amplifier 16 to set the Set-Reset type flip-flop 30. a logical "l" signal passes through OR gate 32 to clock D-type of flop 34 to the "set" state which, in turn, initiates the aforementioned delay timing. Window register 36 is loaded with a digital count value which is representative of the desired delay window, e.g., 5-10 ms. This may be either a fixed, hard-wired register or, alternatively, a programmable register which may be set by telemetry means in a known manner. When the preset enable input (PE) in high, counter 38 is held at a digital count corresponding to the value held in window register 36. When flip-flop 34 is set, the PE on counter 38 is removed, allowing the counter to be decremented with each clock pulse provided on clock line 40. At the end of the preporgrammed window delay interval, counter 38 is decremented to zero, causing the zero detect (ZD) line 42 to go high. The leading edge of the zero detect pulse is used to trigger a ventricle pacing pulse from pulse generator 44, via gates 54 and 56, as required. The pulse generator circuitry 44 converts the leading edge trigger to a pulse of the proper amplitube and duration for effective stimulation of the right ventricle. Note that, since under the assumed conditions flip-flop 30 has been set, AND gate 48 is disabled and, therefore, pulse generator 50 is inhibited from generating a left ventricle pacing pulse.

Next to be considered is the case where a right ventricle contraction has not been sensed within the prescribed window interval. In this case, flip-flop 52 remains reset and AND gate 54 is enabled which allows the zero detect pulse ZD to propagate through OR gate 56 to trigger pulse generator 44, thus stimulating the right ventricle. If, however, a right ventricle contraction has been detected, flip-flop 52 would have been set prior to the generation of the ZD pulse and, in this case, both AND gates 48 and 54 are disabled and no pacing pulse in either ventricle is generated.

It can be seen from the symmetry of the circuit that the operation is identical if the right ventricle contraction precedes the left ventricle contraction by more than the preprogrammed delay interval. In either case, the setting of either flip-flop 30 or 52 causes 52 causes the initiation of the timing window delay interval. When one of these flip-flop sets, the other must set within the window period, otherwise a pacing pulse will be generated in the unsensed ventricle.

The vi-bentriclar pacing control circuitry may be combined with other well-known pacer control circuitry such that the bi-ventriclar mode can be realized in combination with any other pacing mode, such as VVI, DDD, VOO. Line 58 is the logical OR of either of left ventricle event or a right ventricle event. It may be connected to other pacing control circuitry 62 in place of the signal which is normally responsive to only activity in the left ventricle. A sensed ventricle event thus inhibits the generation of a pacing trigger from another pacing circuitry and leaves the control of pacing in the alternate ventricle, as required; to the circuitry of FIG. 1. If line 58 is not activated within the escape interval of the other pacing control circuitry, a paced ventricle trigger signal on line 60 is produced which propagates through both OR gate 62 and OR gate 56 to trigger pacing pulses in both ventricles.

It is also contemplated that when a ventricular depolarization signal is sensed in one or the other of the ventricles, that a stimulating pulse may also be immediately delivered, on an unconditional basis, to both ventricles, via the implanted leads 13 and 15, thus resulting in a coordinated contraction of both ventricles.

The foregoing illustrate preferred arrangements for carrying out the objectives of this invention. Modifications and variations can obviously be made by those skilled in the art without departing from the true spirit and scope of the invention. For instance, the circuit may be employed to simultaneously pace the auricles, instead of ventricles, if such is required to improve pumping efficiency. The arrangement may also be employed as an improvement of conventional pacers thereby to improve their performance. As stated herein, the inventive arrangement can be used in an implanted device or in an external treating, diagnostic or testing device. Accordingly, the invention is limited only by the scope of the appended claims rather than by what is shown and described. Therefore, it is the intent to cover all such modifications and alternate embodiments as may come within the true scope of this invention.

Mower, Morton M.

Patent Priority Assignee Title
10029109, Dec 12 2016 AVIVE SOLUTIONS, INC Defibrillator
10071256, Dec 12 2016 AVIVE SOLUTIONS, INC Defibrillator
10080903, May 23 2007 EBR Systems, Inc. Optimizing energy transmission in a leadless tissue stimulation system
10092186, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management with environmental data
10112054, Dec 12 2016 AVIVE SOLUTIONS, INC Defibrillator
10207115, Aug 31 2005 EBR Systems, Inc. Method and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
10350419, Dec 13 2007 Cardiac Pacemakers, Inc. Supraventricular tachy sensing vector
10352948, Mar 10 2004 Impulse Dynamics NV Protein activity modification
10413196, Dec 18 2002 Cardiac Pacemakers, Inc. Device for reporting heart failure status
10449380, Dec 12 2016 AVIVE SOLUTIONS, INC Defibrillator
10456588, May 23 2007 EBR Systems, Inc. Optimizing energy transmission in a leadless tissue stimulation system
10543376, Dec 12 2016 AVIVE SOLUTIONS, INC Defibrillator
10688307, Mar 25 2008 EBR Systems, Inc. Temporary electrode connection for wireless pacing systems
10903675, Dec 12 2016 AVIVE SOLUTIONS, INC Medical device draw current regulation
10946209, Dec 12 2016 AVIVE SOLUTIONS, INC Tubular, portable automated external defibrillator
11207524, Sep 08 2003 MIROWSKI FAMILY VENTURES, LLC Method and apparatus for intrachamber resynchronization
11318322, Dec 12 2016 Avive Solutions, Inc. Defibrillator
11376439, Aug 31 2004 EBR Systems, Inc. Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
11439815, Mar 10 2003 Impulse Dynamics NV Protein activity modification
11452879, May 23 2007 EBR Systems, Inc. Optimizing energy transmission in a leadless tissue stimulation system
11504538, Dec 13 2007 Cardiac Pacemakers, Inc. Supraventricular tachy sensing vector
11607555, Dec 15 2020 Avive Solutions, Inc. Defibrillator discharge control
11752352, Mar 25 2008 EBR Systems, Inc. Temporary electrode connection for wireless pacing systems
11779768, Mar 10 2004 Impulse Dynamics NV Protein activity modification
6706059, Dec 01 1999 GREATBATCH, LTD NEW YORK CORPORATION Reforming wet-tantalum capacitors in implantable medical devices
6763267, Jul 13 2000 Cardiac Pacemakers, Inc. Ventricular conduction delay trending system and method
6795734, Dec 26 2000 Cardiac Pacemakers, Inc Method and apparatus for display of ventricular electrograms
6920355, Aug 23 1999 Cardiac Pacemakers, Inc. Multi-site hybrid hardware-based cardiac pacemaker
6957100, Dec 26 2000 Cardiac Pacemakers, Inc Method and system for display of cardiac event intervals in a resynchronization pacemaker
6988002, May 21 1999 Cardiac Pacemakers, Inc. Apparatus and method for ventricular rate regularization with biventricular sensing
7027863, Oct 25 1999 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Device for cardiac therapy
7039461, May 13 2000 Cardiac Pacemakers, Inc Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episode
7043305, Mar 06 2002 Cardiac Pacemakers, Inc Method and apparatus for establishing context among events and optimizing implanted medical device performance
7047066, Dec 26 2000 Cardiac Pacemakers, Inc. Method and system for display of cardiac event intervals in a resynchronization pacemaker
7050849, Nov 06 2003 EBR Systems, Inc. Vibrational therapy device used for resynchronization pacing in a treatment for heart failure
7062318, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Electrical muscle controller
7062325, May 21 1999 Cardiac Pacemakers, Inc Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
7069077, May 26 2000 Cardiac Pacemakers, Inc. Rate smoothing control
7113825, May 03 2002 Cardiac Pacemakers, Inc Method and apparatus for detecting acoustic oscillations in cardiac rhythm
7131988, Dec 01 1999 GREATBATCH, LTD NEW YORK CORPORATION Reforming wet-tantalum capacitors in implantable medical devices
7142914, Dec 26 2000 Cardiac Pacemakers, Inc. Mode transition timing for synchronized pacing
7142915, Dec 29 2000 Cardiac Pacemakers, Inc. Apparatus and method for ventricular rate regularization
7167748, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Electrical muscle controller
7171267, Dec 01 1999 GREATBATCH, LTD NEW YORK CORPORATION Reforming wet-tantalum capacitors in implantable defibrillators and other medical devices
7181278, May 21 1999 Cardiac Pacemakers, Inc Apparatus and method for ventricular rate regularization
7181285, Dec 26 2000 Cardiac Pacemakers, Inc Expert system and method
7212860, May 21 1999 Cardiac Pacemakers, Inc Apparatus and method for pacing mode switching during atrial tachyarrhythmias
7231249, Jul 24 2003 Mirowski Family Ventures, L.L.C. Methods, apparatus, and systems for multiple stimulation from a single stimulator
7239914, May 26 2000 Cardiac Pacemakers, Inc Rate smoothing control
7349734, May 15 2000 Cardiac Pacemakers, Inc Method and apparatus for delivering defibrillation shock therapy while reducing electrical dispersion due to ventricular conduction disorder
7383086, Jul 13 2000 Cardiac Pacemakers, Inc. Ventricular conduction delay trending system and method
7383088, Nov 07 2001 Cardiac Pacemakers, Inc Centralized management system for programmable medical devices
7460907, Jul 20 1998 IMPULSE DYNAMICS N V Pacing with hemodynamic enhancement
7460908, May 21 1999 Cardiac Pacemakers, Inc. System providing ventricular pacing and biventricular coordination
7468032, Dec 18 2002 Cardiac Pacemakers, Inc Advanced patient management for identifying, displaying and assisting with correlating health-related data
7536223, Dec 26 2000 Cardiac Pacemakers, Inc. Mode transition timing for synchronized pacing
7558631, Dec 21 2004 EBR SYSTEMS, INC Leadless tissue stimulation systems and methods
7561914, Dec 20 2004 Medtronic, Inc Method of continuous capture verification in cardiac resynchronization devices
7606621, Dec 21 2004 EBR Systems, Inc. Implantable transducer devices
7610092, Dec 21 2004 EBR Systems, Inc. Leadless tissue stimulation systems and methods
7647102, Oct 30 2002 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Cardiac contractility modulation device having anti-arrhythmic capabilities and method of operating thereof
7662104, Jan 18 2005 Cardiac Pacemakers, Inc. Method for correction of posture dependence on heart sounds
7678573, Feb 04 1999 PLURISTEM LTD Method of preparing a conditioned medium from a confluent stromal cell culture
7680530, Dec 26 2000 Cardiac Pacemakers, Inc. Method and system for display of cardiac event intervals in a resynchronization pacemaker
7702392, Sep 12 2005 EBR Systems, Inc. Methods and apparatus for determining cardiac stimulation sites using hemodynamic data
7742814, May 13 2000 Cardiac Pacemakers, Inc. Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episode
7751884, Apr 28 2005 Cardiac Pacemakers, Inc. Flexible neural stimulation engine
7765001, Aug 31 2005 EBR SYSTEMS, INC Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
7769447, Apr 28 2005 Cardiac Pacemakers, Inc. Cardiac pacemaker with table-based pacing mode implementation
7805199, Mar 06 2002 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
7840262, Mar 10 2003 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
7843439, Feb 10 2003 Microsoft Technology Licensing, LLC Touch detection for a digitizer
7848815, Dec 21 2004 EBR Systems, Inc. Implantable transducer devices
7856267, May 21 1999 Cardiac Pacemakers, Inc. Apparatus and method for pacing mode switching during atrial tachyarrhythmias
7890173, Dec 21 2004 EBR Systems, Inc. Implantable transducer devices
7899534, Dec 26 2000 Cardiac Pacemakers, Inc. Expert system and method
7951087, Jan 18 2005 Cardiac Pacemakers, Inc. Method for correction of posture dependence on heart sounds
7953481, Oct 25 1999 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Anti-arrhythmic device and a method of delivering anti-arrhythmic cardiac therapy
7953493, Dec 27 2007 EBR SYSTEMS, INC Optimizing size of implantable medical devices by isolating the power source
7959568, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management for identifying, displaying and assisting with correlating health-related data
7983745, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management with environmental data
7983759, Dec 18 2002 Cardiac Pacemakers, Inc Advanced patient management for reporting multiple health-related parameters
7996087, Dec 21 2004 EBR Systems, Inc. Leadless tissue stimulation systems and methods
8019421, Mar 05 1999 TYLERTON INTERNATIONAL, INC Blood glucose level control
8027719, May 15 2000 Cardiac Pacemakers, Inc. Method and apparatus for delivering defibrillation shock therapy while reducing electrical dispersion due to ventricular conduction disorder
8027721, Mar 24 2003 PHYSIO-CONTROL, INC Balanced charge waveform for transcutaneous pacing
8034000, Jun 08 2005 Cardiac Pacemakers, Inc. Ischemia detection using a heart sound sensor
8043213, Dec 18 2002 Cardiac Pacemakers, Inc Advanced patient management for triaging health-related data using color codes
8064997, May 21 1999 Cardiac Pacemakers, Inc. Method and apparatus for treating irregular ventricular contractions such as during atrial arrhythmia
8099165, Dec 26 2000 Cardiac Pacemakers, Inc. Expert system and method
8103334, Dec 26 2000 Cardiac Pacemakers, Inc. Method and system for display of cardiac event intervals in a resynchronization pacemaker
8108034, Nov 28 2005 Cardiac Pacemakers, Inc. Systems and methods for valvular regurgitation detection
8135465, May 21 1999 Cardiac Pacemakers, Inc. System providing ventricular pacing and biventricular coordination
8160716, Mar 06 2002 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
8228311, Feb 10 2003 Microsoft Technology Licensing, LLC Touch detection for a digitizer
8239021, May 13 2000 Cardiac Pacemakers, Inc. Cardiac pacing system for prevention of ventricular fibrillation and ventricular tachycardia episode
8244371, Mar 18 2005 TYLERTON INTERNATIONAL, INC Pancreas lead
8249703, May 21 1999 Cardiac Pacemakers, Inc. Apparatus and method for ventricular rate regularization
8249725, Jul 24 2003 Mirowski Family Ventures, L.L.C. Methods, apparatus, and systems for multiple stimulation from a single stimulator
8260416, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Electrical muscle controller
8280518, Jan 21 2003 Cardiac Pacemakers, Inc. Recordable macros for pacemaker follow-up
8301247, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Electrical muscle controller
8301252, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management with composite parameter indices
8311629, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Electrical muscle controller
8315701, Dec 21 2004 EBR Systems, Inc. Leadless tissue stimulation systems and methods
8321013, Jan 08 1996 Impulse Dynamics NV Electrical muscle controller and pacing with hemodynamic enhancement
8326416, Mar 10 2003 Impulse Dynamics NV Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue
8346363, Mar 05 1999 TYLERTON INTERNATIONAL, INC Blood glucose level control
8352029, Apr 28 2005 Cardiac Pacemakers, Inc. Flexible neural stimulation engine
8352031, Mar 10 2004 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Protein activity modification
8386036, Dec 26 2000 Cardiac Pacemakers, Inc. Expert system and method
8391974, May 21 1999 Cardiac Pacemakers, Inc. Apparatus and method for pacing mode switching during atrial tachyarrhythmias
8391989, Dec 18 2002 Cardiac Pacemakers, Inc Advanced patient management for defining, identifying and using predetermined health-related events
8417337, Dec 20 2005 Medtronic, Inc. Method of continuous capture verification in cardiac resynchronization devices
8417350, Jan 21 2003 Cardiac Pacemakers, Inc. Recordable macros for pacemaker follow-up
8512220, May 26 2000 Cardiac Pacemakers, Inc. Rate smoothing control
8543215, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management for defining, identifying and using predetermined health-related events
8548583, Mar 10 2004 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Protein activity modification
8600504, Jul 02 2010 Cardiac Pacemakers, Inc. Physiologic demand driven pacing
8639318, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management with composite parameter indices
8666495, Mar 05 1999 TYLERTON INTERNATIONAL, INC Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
8694116, Mar 06 2002 Cardiac Pacemakers, Inc. Method and apparatus for establishing context among events and optimizing implanted medical device performance
8700161, Mar 05 1999 TYLERTON INTERNATIONAL, INC Blood glucose level control
8718773, May 23 2007 EBR Systems, Inc.; EBR SYSTEMS, INC Optimizing energy transmission in a leadless tissue stimulation system
8744558, Sep 05 2003 Mirowski Family Ventures, L.L.C. Method and apparatus for providing ipselateral therapy
8755897, Nov 07 2001 Cardiac Pacemakers, Inc. System and method for remote expert-system medical device programming
8758260, Jun 08 2005 Cardiac Pacemakers, Inc. Ischemia detection using a heart sound sensor
8761905, Jul 24 2003 Mirowski Family Ventures, L.L.C. Methods, apparatus, and systems for multiple stimulation from a single stimulator
8792985, Jul 21 2003 TYLERTON INTERNATIONAL, INC Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
8818511, Dec 15 2000 Cardiac Pacemakers, Inc. Automatic selection of stimulation chamber for ventricular resynchronization therapy
8825152, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue
8934975, Feb 01 2010 TYLERTON INTERNATIONAL, INC Gastrointestinal electrical therapy
9008776, Dec 21 2004 EBR Systems, Inc. Leadless tissue stimulation systems and methods
9061156, Dec 15 2000 Cardiac Pacemakers, Inc. Automatic selection of stimulation chamber for ventricular resynchronization therapy
9101765, Mar 05 1999 TYLERTON INTERNATIONAL, INC Non-immediate effects of therapy
9283392, Mar 25 2008 EBR SYSTEMS, INC Temporary electrode connection for wireless pacing systems
9289618, Jan 08 1996 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Electrical muscle controller
9333364, Aug 31 2005 EBR Systems, Inc. Methods and systems for heart failure treatments using ultrasound and leadless implantable devices
9375566, Dec 18 2002 Cardiac Pacemakers, Inc. Device for reporting heart failure status
9480848, Dec 18 2002 Cardiac Pacemakers, Inc. Advanced patient management with environmental data
9566440, Mar 24 2003 PHYSIO-CONTROL, INC Balanced charge waveform for transcutaneous pacing
9566444, Jul 24 2003 Mirowski Family Ventures, L.L.C. Methods, apparatus, and systems for multiple stimulation from a single stimulator
9713723, Jan 11 1996 Impulse Dynamics NV Signal delivery through the right ventricular septum
9731139, Jul 16 2008 EBR Systems, Inc. Local lead to improve energy efficiency in implantable wireless acoustic stimulators
9821158, Feb 17 2005 TYLERTON INTERNATIONAL, INC Non-immediate effects of therapy
9901739, Sep 08 2003 MIROWSKI FAMILY VENTURES, LLC Method and apparatus for intrachamber resynchronization
9907968, Mar 25 2008 EBR Systems, Inc. Temporary electrode connection for wireless pacing systems
9931503, Mar 10 2003 SANDLEFORD PARK LIMITED, AS SECURITY AGENT Protein activity modification
Patent Priority Assignee Title
3937226, Jul 10 1974 Medtronic, Inc. Arrhythmia prevention apparatus
4088140, Jun 18 1976 Medtronic, Inc. Demand anti-arrhythmia pacemaker
4332259, Sep 19 1979 Intravenous channel cardiac electrode and lead assembly and method
4378020, Aug 20 1981 Pacesetter, Inc Dual chamber pacer
4458677, Sep 19 1979 Intravenous channel cardiac electrode and lead assembly and method
4548203, Jun 01 1982 MEDTRONIC, INC A CORP OF MINNESOTA Sequential-pulse, multiple pathway defibrillation method
4624260, May 07 1985 INTERMEDICS, INC Pacemaker with conditional atrial tracking capability
4774950, Oct 06 1987 Medtronic, Inc Hemodynamically responsive system for and method of treating a malfunctioning heart
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Oct 19 1995MIROWSKI FAMILY VENTURES, LLC(assignment on the face of the patent)
Date Maintenance Fee Events


Date Maintenance Schedule
May 20 20064 years fee payment window open
Nov 20 20066 months grace period start (w surcharge)
May 20 2007patent expiry (for year 4)
May 20 20092 years to revive unintentionally abandoned end. (for year 4)
May 20 20108 years fee payment window open
Nov 20 20106 months grace period start (w surcharge)
May 20 2011patent expiry (for year 8)
May 20 20132 years to revive unintentionally abandoned end. (for year 8)
May 20 201412 years fee payment window open
Nov 20 20146 months grace period start (w surcharge)
May 20 2015patent expiry (for year 12)
May 20 20172 years to revive unintentionally abandoned end. (for year 12)